- Conditions
- Pre-Diabetes
- Interventions
- Functional Ingredient Group, Control Ingredient Group
- Dietary Supplement
- Lead sponsor
- University of Manitoba
- Other
- Eligibility
- 21 Years to 75 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2017
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 91
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Urinary Tract Infections, Vaginal Flora Imbalance
- Interventions
- BioNourish
- Device
- Lead sponsor
- Vaginal Biome Science
- Other
- Eligibility
- Up to 89 Years · Female only
- Enrollment
- 8 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 1
- States / cities
- Newark, Delaware
- Conditions
- Cognitive Functioning
- Interventions
- AlphaBrain
- Dietary Supplement
- Lead sponsor
- Onnits Labs, LLC
- Industry
- Eligibility
- 18 Years to 35 Years
- Enrollment
- 73 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2014
- U.S. locations
- 1
- States / cities
- Chestnut Hill, Massachusetts
- Conditions
- Alzheimer's Disease
- Interventions
- AC-1204, Placebo
- Drug
- Lead sponsor
- Cerecin
- Industry
- Eligibility
- 66 Years to 90 Years
- Enrollment
- 418 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2017
- U.S. locations
- 82
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Hot Springs, Arkansas + 69 more
- Conditions
- External Anogenital Warts
- Interventions
- Podofilox Gel 0.5%, Condylox Topical Gel 0.5%, Placebo Gel
- Drug
- Lead sponsor
- Dermax SA
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 466 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 4
- States / cities
- Miami, Florida • Philadelphia, Pennsylvania • Houston, Texas
- Conditions
- Non-Alcoholic Fatty Liver Disease, NAFLD, Pediatric NAFLD
- Interventions
- Empagliflozin 10 MG, Placebo Oral Tablet
- Drug
- Lead sponsor
- Justin Ryder
- Other
- Eligibility
- 12 Years to 20 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2027 – 2028
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Caffeine
- Interventions
- Caffeine, Placebo
- Drug
- Lead sponsor
- University of Oklahoma
- Other
- Eligibility
- 21 Years to 85 Years
- Enrollment
- 10 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- Oklahoma City, Oklahoma
- Conditions
- Hand Dermatosis
- Interventions
- Mild, moisturizing hand cleanser
- Other
- Lead sponsor
- Wake Forest University
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 46 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 1
- States / cities
- Winston-Salem, North Carolina
- Conditions
- Osteoarthritis Pain of the Knee
- Interventions
- Diclofenac sodium active topical patch, Placebo patch
- Drug
- Lead sponsor
- Noven Pharmaceuticals, Inc.
- Industry
- Eligibility
- 40 Years to 85 Years
- Enrollment
- 370 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2022
- U.S. locations
- 10
- States / cities
- Little Rock, Arkansas • Clearwater, Florida • Doral, Florida + 7 more
- Conditions
- Diabetic Neuropathy
- Interventions
- DA-9801 300mg, DA-9801 600mg, DA-9801 900mg, Placebo
- Drug
- Lead sponsor
- NeuroBo Pharmaceuticals Inc.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 128 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2015
- U.S. locations
- 14
- States / cities
- Lakewood, California • Walnut Creek, California • Milford, Connecticut + 10 more
- Conditions
- Dementia Moderate, Dementia, Mild, Alzheimer Disease
- Interventions
- Xanamem, Placebo
- Drug
- Lead sponsor
- Actinogen Medical
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 247 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 19
- States / cities
- Carlsbad, California • Sherman Oaks, California • Denver, Colorado + 16 more
- Conditions
- Chronic Kidney Diseases, High Cholesterol
- Interventions
- Evolocumab, Placebo
- Drug · Other
- Lead sponsor
- NYU Langone Health
- Other
- Eligibility
- 40 Years to 80 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021
- U.S. locations
- 2
- States / cities
- Mineola, New York • New York, New York
- Conditions
- Food Insecurity, Hypertension, Nutrition, Disease Management
- Interventions
- Food Resources & Kitchen Skills (FoRKS), Enhanced Usual Care (EUC)
- Behavioral
- Lead sponsor
- Indiana University
- Other
- Eligibility
- 35 Years to 75 Years
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 1
- States / cities
- Indianapolis, Indiana
- Conditions
- Warts
- Interventions
- Vitamin D3, Placebo
- Drug
- Lead sponsor
- Stephen P. Merry
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 77 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2023
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
- Conditions
- Erythematous (Type One) Rosacea
- Interventions
- V-101, vehicle
- Drug · Other
- Lead sponsor
- Vicept Therapeutics, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 175 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2010
- U.S. locations
- 7
- States / cities
- San Diego, California • Miami Beach, Florida • Louisville, Kentucky + 4 more
- Conditions
- Chemotherapy-induced Peripheral Neuropathy
- Interventions
- ATX01 10%, ATX01 15%, Placebo
- Drug
- Lead sponsor
- AlgoTherapeutix
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 276 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 8
- States / cities
- Clermont, Florida • Miami, Florida • Port Charlotte, Florida + 5 more
- Conditions
- Anesthesia, Local
- Interventions
- AG-920, Proparacaine Ophthalmic
- Drug
- Lead sponsor
- American Genomics, LLC
- Industry
- Eligibility
- Up to 10 Years
- Enrollment
- 61 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022
- U.S. locations
- 1
- States / cities
- McAllen, Texas
- Conditions
- Upper Limb Spasticity
- Interventions
- DAXI for injection 250 U, DAXI for injection 375 U, DAXI for injection 500 U, Placebo
- Biological · Other
- Lead sponsor
- Revance Therapeutics, Inc.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 83 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 26
- States / cities
- Downey, California • Fountain Valley, California • Long Beach, California + 22 more
- Conditions
- Childhood Obesity
- Interventions
- Phentermine, Placebo
- Drug
- Lead sponsor
- Russell McCulloh, MD
- Network
- Eligibility
- 12 Years to 17 Years
- Enrollment
- 240 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 8
- States / cities
- Wilmington, Delaware • Louisville, Kentucky • Baton Rouge, Louisiana + 5 more
- Conditions
- Actinic Keratosis
- Interventions
- Ingenol Mebutate (Picato®), Generic Ingenol Mebutate, Vehicle Foam
- Drug
- Lead sponsor
- Actavis Inc.
- Industry
- Eligibility
- 18 Years to 95 Years
- Enrollment
- 441 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015
- U.S. locations
- 22
- States / cities
- Fremont, California • San Diego, California • Aventura, Florida + 19 more
- Conditions
- Atherosclerotic Cardiovascular Disease
- Interventions
- Inclisiran
- Drug
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Other
- Eligibility
- 30 Years to 50 Years
- Enrollment
- 1,600 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2032
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Postmenopause, Metabolism, Geroscience
- Interventions
- GLYLO, Placebo
- Other
- Lead sponsor
- Buck Institute for Research on Aging
- Other
- Eligibility
- 45 Years to 65 Years · Female only
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Novato, California
- Conditions
- Foot Ulcer, Diabetic, Diabetic Foot
- Interventions
- NorLeu3-A(1-7) in a gel formulation
- Drug
- Lead sponsor
- US Biotest, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 78 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2011
- U.S. locations
- 12
- States / cities
- Tucson, Arizona • Castro Valley, California • San Diego, California + 8 more
- Conditions
- Postoperative Recovery, Total Knee Arthroplasty
- Interventions
- Xcelerated Recovery Nutritional Supplement
- Drug
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 65 Years and older
- Enrollment
- 80 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2027
- U.S. locations
- 1
- States / cities
- San Francisco, California